Showing results (361-370 of 372) with videos related to
Sort By:
Pageof 38
Nature Genetics|May 27, 2014
Identification of recurrent SMO and BRAF mutations in ameloblastomasRobert T Sweeney, Andrew C McClary, Benjamin R Myers, et al.Plos Medicine|December 30, 2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesDavid S Shames, Luc Girard, Boning Gao, et al.Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.Journal of Pain and Symptom Management|June 28, 2022
Admission Code Status and End-of-life Care for Hospitalized Patients With COVID-19Whitney A Kiker, Si Cheng, Lauren R Pollack, et al.The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.Annals of the American Thoracic Society|April 12, 2017
Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical IllnessMatthew R Baldwin, Jonathan P Singer, Debbie Huang, et al.Journal of Translational Medicine|April 24, 2024
AZGP1 deficiency promotes angiogenesis in prostate cancerRu M Wen, Zhengyuan Qiu, G Edward W Marti, et al.Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.Current Neuropharmacology|January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use DisorderAlireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.Cell Chemical Biology|January 16, 2026
Suppression of pain transmission and behavior by inhibition of peripheral diacylglycerol metabolismYusuf Z Tufail, Carlos Guijas, David A Kummer, et al.Pageof 38